A phase 1/2a study to evaluate the dose, safety, tolerability, and efficacy of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in subjects with peritoneal carcinomatosis from colorectal carcinoma following hyperthermic intraperitoneal chemotherapy

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511853-23-00

Enrollment

Registered

2024-09-23

Start date

2020-05-12

Completion date

2025-04-23

Last updated

2025-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal carcinomatosis (PC) from colorectal carcinoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Norway, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026